IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
IBI343 in Combination Therapy for Advanced Malignant Solid Tumors
Recruiting · NCT07483554 · Registry updated 2026-06-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IBI343 in Combination Therapy for Advanced Malignant Solid Tumors | pancreatic ductal adenocarcinoma | Recruiting | Phase 2 | 2026-06-03 | NCT07483554 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Innovent Biologics (Suzhou) Co. Ltd. | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhejiang University school of medicine | Hangzhou | China | 18 |